Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Lipocine Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +1 vs. Q3 2021
- Shares held
- 10.6M
- +1.43M (+15.6%) vs. Q3 2021
- Total value
- $10.5M
- +$506.9K (+5.1%) vs. Q3 2021
- New holders
- 8
- 8 more added
- Sold out
- 7
- 12 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 186 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,500 | $1.00K | 0.00% | −14,800−90.8% | Reduced |
| Bank of America Corp | 1,167 | $1.00K | 0.00% | −989−45.9% | Reduced |
| Benjamin F. Edwards & Company, Inc. | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,559 | $3.00K | 0.00% | −5,009−66.2% | Reduced |
| JPMorgan Chase & Co | 3,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,000 | $4.00K | 0.00% | +1,926+92.9% | Added |
| Wells Fargo & Company | 4,112 | $5.00K | 0.00% | +10.0% | Added |
| Creative Planning | 10,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 11,715 | $12.0K | 0.00% | −10,952−48.3% | Reduced |
| Cutler Group LP | 13,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 14,187 | $14.0K | 0.00% | +14,187 | New |
| Pinnacle Private Wealth, LLC | 15,250 | $15.0K | 0.00% | +15,250 | New |
| Plante Moran Financial Advisors, LLC | 17,000 | $17.0K | 0.00% | +17,000 | New |
| Jane Street Group, LLC | 22,638 | $22.0K | 0.00% | −14,844−39.6% | Reduced |
| Moloney Securities Asset Management, LLC | 22,500 | $22.0K | 0.00% | −7,500−25.0% | Reduced |
| HRT Financial LP | 24,180 | $23.0K | 0.00% | +24,180 | New |
| Citadel Advisors LLC | 35,605 | $36.0K | 0.00% | −20,015−36.0% | Reduced |
| Charles Schwab Investment Management Inc | 50,000 | $50.0K | 0.00% | +50,000 | New |
| Two Sigma Advisers, LP | 53,000 | $53.0K | 0.00% | +53,000 | New |
| Bank of New York Mellon Corp | 55,204 | $55.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 62,750 | $62.0K | 0.00% | 00.0% | Unchanged |
| RSM US Wealth Management LLC | 65,212 | $65.0K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 66,500 | $66.0K | 0.00% | −339,500−83.6% | Reduced |
| MML Investors Services, LLC | 77,000 | $76.0K | 0.00% | +25,000+48.1% | Added |
| Two Sigma Investments, LP | 102,600 | $102.0K | 0.00% | +102,600 | New |
| Virtu Financial LLC | 117,486 | $116.0K | 0.01% | +87,417+290.7% | Added |
| Susquehanna International Group, LLP | 164,977 | $163.0K | 0.00% | +125,280+315.6% | Added |
| Northern Trust Corp | 168,225 | $167.0K | 0.00% | −346−0.2% | Reduced |
| Price T Rowe Associates Inc | 184,662 | $183.0K | 0.00% | +4,798+2.7% | Added |
| Morgan Stanley | 226,248 | $224.0K | 0.00% | −194,970−46.3% | Reduced |
| Kestra Advisory Services, LLC | 240,300 | $238.0K | 0.00% | −9,118−3.7% | Reduced |
| State Street Corp | 304,617 | $302.0K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 313,111 | $310.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 440,432 | $437.0K | 0.05% | +125,124+39.7% | Added |
| Geode Capital Management, LLC | 824,434 | $817.0K | 0.00% | 00.0% | Unchanged |
| Wealth Effects LLC | 1,489,434 | $1.48M | 0.61% | +1,489,434 | New |
| BlackRock Inc. | 1,594,547 | $1.58M | 0.00% | +14,029+0.9% | Added |
| Vanguard Group Inc | 3,809,970 | $3.78M | 0.00% | −5,378−0.1% | Reduced |
| XTX Topco Ltd | 0 | $0 | 0.00% | −28,762−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −24,075−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −24,075−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −17,539−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Global Wealth Management Investment Advisory, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Prentice Wealth Management LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |